tpan.com Quick Links

2004 HIV Drug Guide

2004 HIV Services Directory

Positively Aware

Positively Aware en Español

HIV Treatment in Prison

We can’t list everything you may need to know on this page, so check out the Inmate's Resource Guide. Don’t forget to let your health care workers know of the organizations which will provide HIV information to them, including a treatment hotline. And by the way, prison health advocates maintain that treating yourself treats the outside community, as well. People coming in and out of the corrections system need treatment and education to help avoid spreading illnesses when they’re out.

Testing

Prison staff cannot take the word of an inmate that he or she has HIV. You may have to be re-tested to confirm your status, or have your health records forwarded.

People who don’t know their HIV status, but believe they may have been at high risk of getting HIV, may want to get tested and if positive, take medication. This may keep them from getting seriously ill while locked up. The last place anyone wants to be when very sick is in a prison. Remember, many people feel fine until their immune system is so badly battered that they find out they have HIV at the point that they have developed AIDS. In fact, many of these people—primarily people of color—die at the time of their AIDS diagnosis. Ironically, only prisoners have a right to free health care in the United States, and practically every prison provides standard-of-care HIV drug combinations.

Drug Combinations

You can get a “regimen,” but it may not be the HIV drug combination you want. Also, not all HIV drugs are available in every institution.

Confidentiality

You know better than we do what goes on in your institution. What we can say is that there is no national plan or advocacy drive to change prison procedures for clinic visits or handing out medications. Again, you can seek help from advocacy groups. A letter from them to the staff can really help. However, one prisoner advocate points out that there’s really no such thing as confidentiality in prison. Word gets out. (If you think you can keep your confidentiality, remember that there’s one HIV triple drug combination in one tablet, taken twice a day: Trizivir, as in tricycle. See Retrovir, Epivir and Ziagen in the 2001 Drug Guide for the three drugs that make up Trizivir, to see if this med might be good for you.)

Side Effects

Ask your health care provider what side effects are associated with the medications being recommended and get tips for how to deal with them if they occur. You can request a prescription to treat some common side effects before going on your meds (such as a sleeping aid to help with Sustiva or Imodium to help with other HIV drugs—write to us for a copy of the annual HIV drug guide from Positively Aware for more suggestions). Remember that you may not experience any side effects at all, so don’t jinx yourself. Psych yourself up instead. Then, too, remember that many side effects often go away within a couple of months. Some quick tips:

• Make sure you’re taking your meds correctly! You could be overdosing yourself. Also, some meds cannot be taken together. Remember, health care providers make mistakes, too. Check the bottle and package insert, the drug guide or whatever you can. Drugs that cannot be taken together are called “contraindicated.”

• Taking medications with food helps prevent nausea. But Videx and Videx-EC must be taken on an empty stomach, and Crixivan may be taken with a very low-calorie, no-fat meal (no cream in that coffee, no butter on that toast), unless you’re taking the Crix along with Norvir or Rescriptor.

• Remain sitting or standing up after dosing. Lying down right away may promote nausea.

• To control nausea, try accupressure. Locate the indentation on the inside of your wrist (measure about two fingers down from the palm of your hand). Apply fingertip pressure for three minutes on each side.

• Get a prescription for an anti-vomiting or anti-nausea medication (such as Compazine, which also treats vomiting). Double check that the medicine does not counteract against your HIV drugs.

• For diarrhea, get an anti-diarrhea medicine, cut back on your fat and sugar intake, and try fiber supplements or Tums. Tums contain calcium, which has been shown, in some people, to reduce the number of loose stools from treatment with Viracept. For both vomiting and diarrhea, don’t forget to drink extra water and juices, and also have soups. The nutrients you are losing need to be replaced so that you can avoid illness.

To DOT or not to DOT?

In directly observed treatment (DOT) a health care provider watches you take your medicines. On the one hand, you may lose confidentiality, plus the opportunity to learn how to take your meds correctly and the ability to control your doses, such as saving them for dinnertime or breakfast. DOT is also authoritarian. On the other hand, you may have a better chance at lowering the amount of HIV in your blood (your viral load). A recently reported study of 50 inmates in Florida found that after a year of DOT, 100% of them had undetectable viral load. In contrast, 81% of the participants in a comparison group outside the prison was undetectable.

Medication delay

“All or none is a good message,” says a leading HIV specialist who’s a prison doctor. In other words, temporarily stopping your meds is better than spotty doses. To a large degree, HIV medications are about, “Every dose, on time, under the right conditions.” The idea generally hasn’t sunk in with all prison administrators and correctional officers.

If you can’t take your entire HIV drug combination, don’t just take the ones that are available. Stop taking them all until you can be sure that you can take each and every dose. If your viral load is undetectable, you have a good chance of being undetectable again when you go back on all the meds.

If your viral load is detectable, you’re still better off stopping all the meds at the same time. Taking only some of your drugs can make your virus develop resistance, which might make the drugs ineffective. You also increase the risk of transmitting resistant virus to someone else. This limits treatment options for a newly infected person.

You may want to set aside all your doses for the first few days you’re supposed to be starting your combo, to save them in case the prison runs out of one. It’s not legal, but there you go. Lots of people use this trick.

Remember that Sustiva and Viramune last a lot longer in the body than the other meds. They should be stopped two days before the other meds are (although there’s still no conclusive evidence that this will actually help). Stopping them early, of course, may not be within anyone’s control in a prison. All in all, the common delays in giving medications is “a scary situation,” says the prison doc.

Telemedicine

Telemedicine allows the prison’s primary health care provider to communicate with an HIV specialist, or the specialist to “see” a prison patient, without costly and time-consuming travel to each other’s clinic. It involves the use of “electronic information and communications technology,” such as computers, telephone consultations and interactive video cameras. This area of medicine is still being developed.

TB

Tuberculosis disease in the lungs might be mistaken for other causes of pneumonia. The TB skin test and the chest x-ray used to diagnose TB can be falsely normal in people with HIV. A sputum test is recommended when there are respiratory symptoms in HIV-positive inmates, even if they were previously found to have negative tests for TB. TB symptoms include fatigue, weight loss, fever, night sweats, chest pain, coughing up blood and a cough that doesn’t go away.

Rifabutin should be used instead of rifampin for people taking protease inhibitors (Agenerase, Crixivan, Fortovase, Kaletra, Norvir and Viracept) or non-nukes (Sustiva, Rescriptor and Viracept) to treat TB. Rifabutin dose must be cut in half with Agenerase, Crixivan or Viracept, and it should not be given with Norvir or Rescriptor. Centers for Disease Control and Prevention (CDC) recommendations call for using a four-drug combination with rifabutin for the first two months. After two months, if there is no drug resistance the treatment can usually be decreased to two drugs. (However, the CDC recently warned the public again about the rare potential for hepatitis with the two-drug regimen of rifampin and pyrazinamide). Healthcare workers can check the March 1999 HEPP News for tables listing different regimens and dosages to use. Pregnant women cannot take the oral drug pyrazinamide (PZA) or the intramuscular injection drug streptomycin (SM). Isoniazid should be given with pyridoxine to reduce the risk of neurotoxicity. Treatment of active disease should never be delayed because of pregnancy. Prophylactic (prevention) treatment for those who are infected but do not have active disease can be delayed.

Depression and stress kills

Both inmates and people living with HIV have higher rates of depression than the general population. Prisoners also have higher rates of mental illness, especially those with substance abuse. Substance abuse, for anyone, is highly related to untreated underlying illnesses such as anxiety disorders, and is also related to post-traumatic stress disorders, such as surviving childhood physical and sexual abuse. Some even argue that in fact, the U.S. uses prisons as poor substitutes for mental health and substance abuse care.

The anti-depressants in the class of selective serotonin reuptake inhibitors (SSRIs) has few interactions with HIV meds. These drugs include Zolof, Paxil, Prozac and Wellbutrin. The tricyclic anti-depressants (Elavil or amitriptyline) tend to suppress cognitive function (thinking and analyzing abilities), and people with HIV may already have their cognitive functions under stress. Health care providers should look for underlying cognitive problems in order to avoid a misdiagnosis of depression or other condition, since neurological problems overlap with mental health difficulties. Inmates with these problems may be subject to retaliation from other inmates or prison staff because they fail to understand or remember rules, and they may exhibit erratic behavior.

Drug use

It’s estimated that three out of four people in prison have drug or alcohol problems. People who continue to use when released have a greater risk of returning to prison. They also have a greater risk getting reinfected with hepatitis C, which may have already cleared their body.

Inside prison, check out drug treatment if you can get it. If you continue to use, try not to share equipment. You need to try to avoid hepatitis C as well as new strains of HIV. Again, this may not be in your control, since condoms, dental dams and bleach are contraband in the vast majority of prisons, and methadone is not always available. (Remember that full strength bleach is needed to clean needles, with lots of rinsing—four shots of bleach, each shaken and then rinsed.)

Release

If your system doesn’t help plan for your health care after release (see “Recommendations for Prisoners”), start planning on your own several months before your parole date. Contact the advocacy groups in listed in “Resources.”

 

Special thanks to Dr. Joseph Bick, Director of HIV Treatment Services for the California Medical Facility, California Department of Corrections, and an editor of HEPP News, for reviewing this article.

Activist victory ends Mississippi segregation

In April, the Corrections Commissioner of Mississippi, Robert L. Johnson, agreed to adopt the recommendations of the HIV/AIDS Task Force he appointed last year. No longer will inmates with HIV be barred from participation in educational, treatment and vocational training opportunities. Alabama now stands alone as the only state that continues to deny access to programs for positive prisoners and allows segregation (including housing). Congratulations to the prison activists and advocates who worked for this major progress, which included the folks at the American Civil Liberties Union HIV Prison Project.—EV

Hep C—an epidemic in itself

It’s been estimated that about a third of the people in the U.S. with hepatitis C have gone through jail or prison. About 20% of prisoners have chronic hepatitis C virus (HCV), 10 times more than the 2% found in the general population. That 2% is more than double the percent of people living with HIV. According to an article in HEPP News, “Much of the controversy around HCV testing and treatment in corrections is related to delayed recognition of the important role incarcerated individuals play in the transmission of hepatitis in the communities after they are released.” Other problems are the high cost of what is often an ineffective therapy, and the fact that while HCV is found in more than 80% of people with a history of injection drug use, many drug users will continue to use drugs after leaving prison and therefore continue to get infected with hep C. Most of the following information is taken from HEPP News. For more information on hep C in prison, see resources on page 35.—EV

• Inmates should be routinely tested for hepatitis (Centers for Disease Control and Prevention recommendation).

• If positive for HCV, get hepatitis C viral load and genotype (the strain of hep C) and do liver function tests (LFTs). LFTs measure AST, ALT, LDH and GGT. Elevated levels indicate liver damage.

• Be aware that unlike HIV viral load, HCV viral load is often in the millions. Genotypes 2 and 3 respond best to treatment, but 70% of the U.S. infections are genotype 1.

• People with hep C should be vaccinated against hepatitis A or B. The first HBV shot alone provides about 50% protection. Although the three shots are to be completed within four months, their protection is still good if extended beyond that time.

• Liver biopsy is the best way to determine the extent of liver damage. Unfortunately, doing a liver biopsy is expensive and often impractical under prison conditions. (However, the State of Florida makes them routine for monitoring prisoners with hepatitis and gets them done for $200 each.) Therefore, even though the other tests (viral load and LFTs) are not accurate predictors of liver damage, some prison health advocates believe these tests should be used to determine treatment.

• People should be prepared for the difficult side effects: fatigue, muscle aches, fever, chills, nausea, headaches, weight loss, reduced white blood cell and platelet counts, irritability, depression and even suicidal thoughts. They should be checked for depression and anemia within the first two weeks of treatment.

• People co-infected with HIV and HCV have a 12 to 300 times greater risk of developing liver cancer.

| Positively Aware | 2004 HIV Drug Guide | Positively Aware en español |

|Chicago Area HIV Services Directory | Publications Home |

| Publications | Client Services | MOCHA | Events | Helping TPAN |

| Contacts and Staff | About TPAN | Ask TPAN | Links | TPAN Home |